A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative - PubMed (original) (raw)
Clinical Trial
A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative
J A DiPalma et al. Am J Gastroenterol. 2000 Feb.
Abstract
Objective: This study was designed to determine the efficacy and safety of a new laxative, Braintree polyethylene glycol (PEG) laxative (Miralax, Braintree Laboratories, Braintree, MA).
Methods: This investigation was designed as a placebo-controlled, blinded, randomized, multicenter parallel trial. Study subjects were constipated but otherwise healthy outpatients who had < or =2 stools during a 7-day qualification period. Braintree PEG laxative 17 g or dextrose placebo p.o. in 8 oz of water for a 14-day treatment period. A diary recorded each bowel movement and subjective symptoms of stool consistency, ease of passage, cramps, and flatus. CBC, blood chemistries and urinalysis were performed before and after the treatment period.
Results: There were 151 randomized subjects, 131 female and 20 male. An increase in bowel movement frequency was observed with the PEG laxative as compared to placebo (p<0.001), with the greatest difference in efficacy in wk 2 of treatment (p<0.001). By wk 2 of treatment, on average, placebo subjects had 2.7 bowel movements/wk and PEG-treated study subjects had 4.5 movements/wk (p<0.01), or more than one bowel movement every 2 days. Investigator (p<0.005) and patient (p<0.001) subjective assessment of perception of treatment effectiveness, and patient evaluations of stool consistency and passage showed significant improvement in the active treatment group (p<0.001). There were no significant differences in laboratory changes or adverse experiences recorded between groups.
Conclusion: Braintree PEG laxative is safe and effective in the short term for the treatment of constipation.
Comment in
- A new weapon for the arsenal in the war against constipation?
Lasch HM, Bozymski EM. Lasch HM, et al. Am J Gastroenterol. 2000 Feb;95(2):341-2. doi: 10.1111/j.1572-0241.2000.t01-1-01788.x. Am J Gastroenterol. 2000. PMID: 10685733 No abstract available.
Similar articles
- New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study.
Cleveland MV, Flavin DP, Ruben RA, Epstein RM, Clark GE. Cleveland MV, et al. South Med J. 2001 May;94(5):478-81. South Med J. 2001. PMID: 11372795 Clinical Trial. - A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.
Dipalma JA, Cleveland MV, McGowan J, Herrera JL. Dipalma JA, et al. Am J Gastroenterol. 2007 Jul;102(7):1436-41. doi: 10.1111/j.1572-0241.2007.01199.x. Epub 2007 Mar 31. Am J Gastroenterol. 2007. PMID: 17403074 Clinical Trial. - A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation.
Di Palma JA, Cleveland MV, McGowan J, Herrera JL. Di Palma JA, et al. Am J Gastroenterol. 2007 Sep;102(9):1964-71. doi: 10.1111/j.1572-0241.2007.01365.x. Epub 2007 Jun 15. Am J Gastroenterol. 2007. PMID: 17573794 Clinical Trial. - Use of low dose polyethylene glycol solutions in the treatment of functional constipation.
Badiali D, Corazziari E. Badiali D, et al. Ital J Gastroenterol Hepatol. 1999 Nov;31 Suppl 3:S245-8. Ital J Gastroenterol Hepatol. 1999. PMID: 10726228 Review. - Systematic review and meta analysis: polyethylene glycol in adults with non-organic constipation.
Belsey JD, Geraint M, Dixon TA. Belsey JD, et al. Int J Clin Pract. 2010 Jun;64(7):944-55. doi: 10.1111/j.1742-1241.2010.02397.x. Int J Clin Pract. 2010. PMID: 20584228 Review.
Cited by
- Monolithic Polyepoxide Membranes for Nanofiltration Applications and Sustainable Membrane Manufacture.
Anderson MB, Danna RA, French C, Wu J, Thiel MN, Yang Z, Hoek EMV, Kaner RB. Anderson MB, et al. Polymers (Basel). 2024 Sep 11;16(18):2569. doi: 10.3390/polym16182569. Polymers (Basel). 2024. PMID: 39339033 Free PMC article. - Intravenous Polyethylene Glycol Alleviates Intestinal Ischemia-Reperfusion Injury in a Rodent Model.
Clarysse M, Accarie A, Panisello-Roselló A, Farré R, Canovai E, Monbaliu D, De Hertogh G, Vanuytsel T, Pirenne J, Ceulemans LJ. Clarysse M, et al. Int J Mol Sci. 2023 Jun 28;24(13):10775. doi: 10.3390/ijms241310775. Int J Mol Sci. 2023. PMID: 37445954 Free PMC article. - 2022 Seoul Consensus on Clinical Practice Guidelines for Functional Constipation.
Cho YS, Lee YJ, Shin JE, Jung HK, Park SY, Kang SJ, Song KH, Kim JW, Lim HC, Park HS, Kim SJ, Cha RR, Bang KB, Bang CS, Yim SK, Ryoo SB, Kye BH, Ji WB, Choi M, Sung IK, Choi SC; Korean Society of Neurogastroenterology and Motility. Cho YS, et al. J Neurogastroenterol Motil. 2023 Jul 30;29(3):271-305. doi: 10.5056/jnm23066. J Neurogastroenterol Motil. 2023. PMID: 37417257 Free PMC article. Review. - Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints.
Menees SB, Lembo AJ, Chey WD. Menees SB, et al. Can J Gastroenterol Hepatol. 2022 Sep 9;2022:3533504. doi: 10.1155/2022/3533504. eCollection 2022. Can J Gastroenterol Hepatol. 2022. PMID: 36120087 Free PMC article. Clinical Trial. - Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics.
Han MN, Finkelstein DI, McQuade RM, Diwakarla S. Han MN, et al. J Pers Med. 2022 Jan 21;12(2):144. doi: 10.3390/jpm12020144. J Pers Med. 2022. PMID: 35207632 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical